Motahareh Ghodrati1*, Abdollah Amini2 and Omid Imani2
Covid-19 patients show a range of disturbance, the most significant of which is an acute respiratory syndrome. 17% -29% of them indicated more severe complications of pulmonary disorders including pneumonia and Acute Respiratory Distress Syndrome (ARDS). Preliminary studies have reported an increase in inflammatory mediators and cytokines (cytokine storm) in patients with COVID-19. A Cardiopulmonary Bypass (CPB) alone triggers a potent stimulant to release of inflammatory response throughout the body. The synergistic effect of COVID-19 and CPB development postoperative risks in cardiac surgery patients. The patient was a 53-year-old man with coronary artery disease. After the end of the CPB observed pulmonary dysfunction and decreased Partial pressure of oxygen (PO2) and O2 Saturation (O2sat) in Arterial Blood Gas (ABG). In Chest CT, the patient’s previous pulmonary lesions were exacerbated after surgery, and pneumonia was diagnosed based on the opinion of an infectious disease specialist.
English 
Spanish 
Chinese 
German 
French 
Japanese 
Portuguese 
Hindi